R68070, a combined thromboxane synthase inhibitor and thromboxane receptor antagonist, inhibits human platelet activation in vivo: a comparison with aspirin - Hoet, B; Falcon, C; Arnout, J; Deckmyn, H; Vermylen, J (Blood, 1990)